What does Teprotumumab (Tepezza) do in plain English—and how does it work inside your body?
Teprotumumab is an FDA-regulated Insulin-like Growth Factor-1 Receptor Inhibitor (RxNorm RxCUI RXN-75987130-3196). Mechanistically, Delivered via 500 mg/1 Injection, Powder, Lyophilized, for Solution (intravenous-route; NDC 75987-130), Teprotumumab mediates insulin-like growth factor-1 receptor inhibitor physiological effects manufactured/labeled by Horizon Therapeutics USA, Inc. with dose-dependent receptor occupancy and systemic clearance. [1][2].
When your doctor writes a prescription for Teprotumumab (RxNorm RxCUI RXN-75987130-3196, also dispensed under brand names including Tepezza), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Delivered via 500 mg/1 Injection, Powder, Lyophilized, for Solution (intravenous-route; NDC 75987-130), Teprotumumab mediates insulin-like growth factor-1 receptor inhibitor physiological effects manufactured/labeled by Horizon Therapeutics USA, Inc. with dose-dependent receptor occupancy and systemic clearance. [2].
Across real-world patient logs on dotMD (75% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Teprotumumab tablet bottle and confirm with your pharmacist that it matches your prescribed strength (500 mg/1 Injection, Powder, Lyophilized, for Solution, 500 mg).